Related Experiment Video
Updated: Feb 15, 2026
12:03
Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
Published on: June 7, 2016
18.5K
Receptor-specific crosstalk between prostanoid E receptor 3 and bombesin receptor subtype 3
Yan Zhang1, Yanfang Liu2, Lehao Wu1
1School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China.
Summary
Prostaglandins, particularly PGE2, act as ligands for the Bombesin receptor subtype 3 (BRS-3). This interaction is potentiated by the EP3 receptor, revealing a novel crosstalk between GPCRs with potential therapeutic implications.
Area of Science:
- Molecular Pharmacology
- G Protein-Coupled Receptors (GPCRs)
- Signal Transduction
Background:
- Bombesin receptor subtype 3 (BRS-3), a GPCR, has roles in the CNS, peripheral tissues, and tumors, but its natural ligand remains unidentified.
- Understanding BRS-3's function is crucial for its therapeutic targeting, yet its endogenous ligand and activation mechanisms are poorly understood.
Purpose of the Study:
- To identify the natural ligand for the Bombesin receptor subtype 3 (BRS-3).
- To investigate the interaction between BRS-3 and other receptors, specifically EP receptors, in response to prostaglandin signaling.
- To elucidate the functional crosstalk between BRS-3 and EP3 receptors and its impact on cellular signaling.
Main Methods:
- Screening of toad skin extracts to identify potential ligands for BRS-3.
- Pharmacological characterization of prostaglandin activity on BRS-3 in transfected HEK cells.
- Investigating the role of EP receptors in mediating differential prostaglandin E2 (PGE2) effects.
- Reconstitution of BRS-3 and EP3 receptors in CHO cells to study their functional interaction.
Main Results:
- Prostaglandins, with PGE2 as the most potent, were identified as putative ligands for BRS-3, fulfilling criteria for receptor affinity, selectivity, and specificity.
- PGE2 exhibited differential activation of BRS-3 depending on the cellular environment, with EP3 receptor identified as a key mediator of this effect.
- Co-expression of BRS-3 and EP3 receptors in CHO cells demonstrated a specific and potentiating interaction, enhancing PGE2 signaling.
Conclusions:
- This study identifies prostaglandins, particularly PGE2, as functional ligands for BRS-3.
- A novel receptor-specific functional crosstalk between BRS-3 and EP3 receptors potentiates PGE2 signaling.
- The discovered GPCR crosstalk has significant implications for understanding BRS-3 pathophysiology and developing targeted therapies.
Related Concept Videos
01:31Internal Receptors
74.8K
Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
74.8K
01:31Adrenergic Receptors: ɑ Subtype
3.0K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
3.0K
01:26Adrenergic Receptors: β Subtype
3.9K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
3.9K
01:38Receptor-mediated Endocytosis
111.6K
Overview
111.6K
01:00Enzyme-linked Receptors
86.8K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
86.8K
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
715
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
715